Non-HLA antibodies: Angiotensin II type 1 receptor (Anti-AT1R) and endothelin-1 type A receptor (Anti-ETAR) are associated with renal allograft injury and graft loss

Transplantation Proceedings

Volumn 46, Issue 8, 2014, Pages 2618-2621

  Banasik, M ^a   Boratynska M ^a   Koscielska Kasprzak K ^a   Kaminska D ^a   Zmonarski, S ^a   Mazanowska, O ^a   Krajewska, M ^a   Bartoszek, D ^a   Zabinska M ^a   Myszka, M ^a   Kaminska M ^b   Halon A ^a   Dawiskiba, T ^a   Szyber, P ^a   Sas, A ^a   Klinger, M ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTIBODY; ANTIBODY; AZATHIOPRINE; BASILIXIMAB; COMPLEMENT COMPONENT C4D; CREATININE; CYCLOSPORIN; ENDOTHELIN 1 TYPE A RECEPTOR ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR; ENDOTHELIN A RECEPTOR; HLA ANTIGEN;

ACUTE VASCULAR REJECTION; ADULT; CHRONIC GLOMERULONEPHRITIS; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PYELONEPHRITIS; RENAL GRAFT DYSFUNCTION; ADVERSE EFFECTS; ALLOTRANSPLANTATION; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ENDOTHELIN A; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84910126741     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.09.029     Document Type: Conference Paper

References (17)

1. D. Dragun, R. Catar, and A. Philippe Non-HLA antibodies in solid organ transplantation: recent concepts and clinical relevance Current Opin Organ Transplant 18 2013 430 435
2. M. Giral, Y. Foucher, and A. Dufay Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss Am J Transplant 13 2013 2567 2576
3. M. Taniguchi, L.M. Rebellato, and J. Cai Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies Am J Transplant 13 2013 2577 2589
4. N.E. Hiemann, R. Meyer, and E. Wellnhofer Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation Transplantation 94 2012 919 924
5. M. Banasik, M. Boratynska, and K. Koscielska-Kasprzak The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome Transplant Proc 45 2013 1449 1452
6. M. Yanagisawa, H. Kurihara, and S. Kimura A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415
7. D. Dragun, and B. Hegner Non-HLA antibodies post-transplantation: clinical relevance and treatment in solid organ transplantation Contrib Nephrol 162 2009 129 139
8. P.I. Terasaki A personal perspective: 100-year history of the humoral theory of transplantation Transplantation 93 2012 751 756
9. M. Banasik, and M. Klinger Chronic allograft nephropathy - immunologic and nonimmunologic factors Ann Transplant 11 2006 7 10
10. M. Banasik, M. Boratynska, and B. Nowakowska C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients Transplant Proc 39 2007 2718 2720
11. M. Banasik, M. Boratynska, and B. Nowakowska Variability in donor-specific alloantibody production after transplantation Transplant Proc 39 2007 2715 2717
12. B.D. Tait, C. Susal, and H.M. Gebel Consensus guidelines on the testing and clinical management issues associated with HLA and Non-HLA antibodies in transplantation Transplantation 95 2013 19 47
13. M. Banasik, M. Boratynska, and K. Koscielska-Kasprzak The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes Transpl Immunol 30 2013 24 29
14. M. Banasik, M. Boratynska, and K. Koscielska-Kasprzak Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation Transplant Proc 45 2013 1462 1465
15. K. Mizutani, P. Terasaki, and A. Rosen Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure Am J Transplant 5 2005 2265 2272
16. M.P. Schneider, E.I. Boesen, and D.M. Pollock Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease Annu Rev Pharmacol Toxicol 47 2007 731 759
17. S. Bilalic, M. Veitinger, and K.H. Ahrer Identification of Non-HLA antigens targeted by alloreactive antibodies in patients undergoing chronic hemodialysis J Proteome Res 9 2010 1041 1049